HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 1,537-1,548 of 1,979
Drug study icon
Not recruitingEUCTR 2021-002126-24

A Multi-region, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating SEP-4199 Controlled Release (CR) for the Treatment of Major Depressive Episode Associated ...

This study isn't currently recruiting.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria
Depression, BipolarityHistorical research record
Countries
Bulgaria, Croatia, Slovakia
Sponsor
Sunovion Pharmaceuticals Inc.
Drug study icon
Not recruitingEUCTR 2005-004391-21

A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP STUDY, COMPARING THE EFFICACY AND TOLERABILITY OF ZIPRASIDONE (ZELDOX®, GEODON®) VS OLANZAPINE (ZYPREXA®) IN THE TREATMENT AND MAINTENANCE OF...

This study isn't currently recruiting.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In France
BipolarityHistorical research record
Countries
France, Germany, Greece, + 2 others
Sponsor
Pfizer S.A.
Drug study icon
Not recruitingEUCTR 2004-000113-18

A randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy, safety and tolerability of licarbazepine 750-2500 mg/d combined with risperidone in the treatment of mani...

This study isn't currently recruiting.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Finland
BipolarityHistorical research record
Countries
Finland, Hungary, Spain
Sponsor
Novartis Farmacéutica, S.A.
Drug study icon
Not recruitingEUCTR 2007-002551-17

Randomised, double-blind, parallel-group, placebo-controlled, and active referenced study of Lu AA34893 to evaluate the efficacy and safety of three doses Lu AA34893 and quetiapine versus placebo i...

This study isn't currently recruiting.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Austria
Bipolarity, DepressionHistorical research record
Countries
France, United Kingdom, Belgium, + 5 others
Sponsor
H. Lundbeck a/s
Other study type icon
UnknownNCT06515522

A Biological Signature for the Early Differential Diagnosis of Psychosis

Official study title

A Biological Signature for the Early Differential Diagnosis of Psychosis: Unveiling the Differences Between Mood Disorders and Schizophrenia With Multimodal Machine Learning Techniques

Current recruitment status is unconfirmed.

Location not clearly listed
Schizophrenia, Depression, ...Observational studyAges 18–65
Countries
Sponsor
IRCCS San Raffaele

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.